Table 3.
Mortality Predictors among NSCLC.
Mortality | Odd ratio | 95% confidence interval | P-value |
---|---|---|---|
Age | 1.01 | 0.99–1.04 | 0.31 |
Sex | |||
Female (ref.) | |||
Male | 1.26 | 0.59–2.69 | 0.56 |
Extension | |||
Localized (ref.) | 1 | ||
Regional by direct extension | 0.77 | 0.14–4.16 | 0.76 |
Regional by lymph node | 0.81 | 0.12–5.22 | 0.82 |
Regional by both direct extension and lymph node | 2.15 | 0.22–20.70 | 0.51 |
Regional nos | 1.26 | 0.06–27.56 | 0.88 |
Distance metastasis/systematic disease | 3.29 | 1.22–8.85 | 0.02 |
Topography | |||
Main bronchus (ref.) | 1 | ||
Upper lobe | 1.67 | 0.38–7.29 | 0.50 |
Middle lobe | 2.67 | 0.34–21.08 | 0.35 |
Lower lobe | 1.42 | 0.31–6.58 | 0.65 |
Overlapped lesion | 1.45 | 0.17–12.25 | 0.73 |
Not otherwise specified | 2.23 | 0.50–10.01 | 0.30 |
Laterality | |||
Left (ref.) | 1.00 | ||
Not paired | 1 (empty) | ||
Right origin | 1.04 | 0.54–2.03 | 0.90 |
Bilateral (side of origin unknown or single primary) | 0.25 | 0.04–1.51 | 0.13 |
Paired no information concerning laterality | 0.84 | 0.20–3.55 | 0.81 |
Year of diagnosis | |||
2009 (ref.) | 1.00 | ||
2010 | 0.96 | 0.41–2.23 | 0.92 |
2011 | 2.14 | 0.77–5.95 | 0.14 |
2012 | 1.10 | 0.45–2.67 | 0.83 |
2013 | 0.36 | 0.14–0.93 | 0.04 |